Over the years, Bridget has successfully developed predictive models to support drug discovery initiatives towards infections caused by various protists and mycobacteria and most recently the SARS-CoV-2 virus. Bridget is experienced in translational science and has previously organised clinical trials at the MRC Unit in The Gambia and at the Cambridge University Hospitals, UK and with widespread collaborations at leading institutions in the USA, Spain, Portugal, Germany, Sweden, France and Brazil and established partnerships with international organisations such as UNESCO, WHO and Schlumberger.
I have designed capacity-building programmes in health, education, and gender streaming initiatives at the Science Resources Africa programme. I currently manage the foundation-organised academy programme for researchers working on antimicrobial resistance in Africa.
I also liaise with stake holders including national and regional representatives of the World Health Organisation and the Centers for Disease Control and Prevention to support research translation and engagement initiatives with researchers in universities and public health institutions